Chugai Pharma Q1 Results Climb, Backs FY26 Outlook

AI Briefing

• – Chugai Pharma's Q1 profits rise, company maintains FY26 outlook.
• – Japanese pharmaceutical company reports higher revenues and profits.
• – Chugai maintains fiscal 2026 outlook after Q1 results.